41 – 50 of 384
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Pre-clinical effects of highly potent MEK1/2 inhibitors on rat cerebral vasculature after organ culture and subarachnoid haemorrhage
(
- Contribution to journal › Article
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article
-
Mark
Rimegepant oral disintegrating tablet for migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
(
- Contribution to journal › Article
-
Mark
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
(
- Contribution to journal › Scientific review
-
Mark
Does inflammation have a role in migraine?
2019) In Nature Reviews Neurology(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
(
- Contribution to journal › Article
-
Mark
Perivascular neurotransmitters : Regulation of cerebral blood flow and role in primary headaches
(
- Contribution to journal › Article
- 2018
-
Mark
PACAP38 and PAC1 receptor blockade : a new target for headache?
(
- Contribution to journal › Scientific review
-
Mark
Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans
(
- Contribution to journal › Article